HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Lu Selected Research

Activating Transcription Factor 1

1/2019The human ATF1 rs11169571 polymorphism associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.
12/2016The protein level and transcription activity of activating transcription factor 1 is regulated by prolyl isomerase Pin1 in nasopharyngeal carcinoma progression.
1/2012Activating transcription factor 1 is a prognostic marker of colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Lu Research Topics

Disease

185Neoplasms (Cancer)
06/2022 - 01/2000
60Inflammation (Inflammations)
02/2022 - 05/2002
29Neoplasm Metastasis (Metastasis)
06/2022 - 01/2010
28Carcinogenesis
10/2022 - 02/2006
27Breast Neoplasms (Breast Cancer)
06/2022 - 02/2011
27Infections
12/2020 - 08/2003
25Non-alcoholic Fatty Liver Disease
01/2022 - 05/2013
22Melanoma (Melanoma, Malignant)
01/2021 - 08/2006
20Lung Neoplasms (Lung Cancer)
03/2022 - 02/2006
20Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2012
20Prostatic Neoplasms (Prostate Cancer)
05/2021 - 08/2007
19Hypertension (High Blood Pressure)
06/2022 - 04/2013
18Body Weight (Weight, Body)
06/2022 - 04/2004
18Insulin Resistance
01/2022 - 02/2008
15Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 09/2013
15Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2006
15Obesity
01/2022 - 08/2011
15Wounds and Injuries (Trauma)
09/2020 - 10/2010
15Alzheimer Disease (Alzheimer's Disease)
01/2019 - 05/2009
14Pain (Aches)
07/2022 - 01/2008
14Reperfusion Injury
01/2022 - 02/2004
13Fibrosis (Cirrhosis)
01/2022 - 09/2002
13Carcinoma (Carcinomatosis)
07/2021 - 01/2000
13Atherosclerosis
01/2021 - 05/2002
12Hypoxia (Hypoxemia)
01/2022 - 08/2006
12Brain Ischemia (Cerebral Ischemia)
01/2021 - 12/2008
12Acute Lung Injury
12/2020 - 08/2010
11Leukemia
01/2021 - 12/2002
11Necrosis
09/2020 - 07/2003
11Hyperplasia
01/2018 - 09/2002
10Stroke (Strokes)
06/2022 - 11/2009
10Fatty Liver
01/2022 - 08/2014
10Infarction (Infarctions)
01/2021 - 04/2008
10Hyperglycemia
01/2021 - 06/2005
10Parkinson Disease (Parkinson's Disease)
01/2021 - 12/2008
10Ischemia
12/2016 - 02/2004
9Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 04/2018
9Myocardial Ischemia (Ischemic Heart Diseases)
04/2022 - 08/2004
9Cognitive Dysfunction
04/2022 - 02/2015
9Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2013
9Myocardial Infarction
01/2021 - 12/2010
9Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2005
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2006
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

85Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2004
45Biomarkers (Surrogate Marker)IBA
05/2022 - 06/2006
34Pharmaceutical PreparationsIBA
07/2022 - 09/2010
27RNA (Ribonucleic Acid)IBA
10/2022 - 11/2011
24CytokinesIBA
01/2022 - 05/2008
24Messenger RNA (mRNA)IBA
01/2022 - 07/2006
21LipidsIBA
05/2022 - 04/2006
21MicroRNAs (MicroRNA)IBA
05/2022 - 02/2012
21Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2011
19LigandsIBA
01/2022 - 05/2002
18Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2010
18Biological ProductsIBA
01/2022 - 11/2007
18EnzymesIBA
01/2020 - 08/2004
17AntigensIBA
01/2022 - 06/2007
16DNA (Deoxyribonucleic Acid)IBA
10/2022 - 07/2007
13Phosphotransferases (Kinase)IBA
01/2022 - 07/2006
13Neuroprotective AgentsIBA
01/2021 - 12/2008
12alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 04/2013
12Long Noncoding RNAIBA
01/2022 - 10/2016
12Small Interfering RNA (siRNA)IBA
01/2021 - 10/2006
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 04/2003
11AntioxidantsIBA
01/2021 - 03/2007
11Interleukin-6 (Interleukin 6)IBA
09/2020 - 08/2011
10Therapeutic UsesIBA
01/2022 - 07/2014
10Blood Glucose (Blood Sugar)IBA
01/2022 - 12/2009
10Propofol (Diprivan)FDA LinkGeneric
01/2022 - 05/2012
10AcidsIBA
09/2021 - 08/2007
10Insulin (Novolin)FDA Link
01/2021 - 02/2008
10ApolipoproteinsIBA
11/2013 - 05/2002
9CalciumIBA
06/2022 - 11/2005
9KetamineFDA LinkGeneric
05/2022 - 12/2016
9SteroidsIBA
02/2022 - 11/2009
9Polysaccharides (Glycans)IBA
04/2020 - 06/2010
9claudin 6IBA
08/2019 - 08/2012
8Peptides (Polypeptides)IBA
01/2022 - 07/2012
8CollagenIBA
01/2022 - 02/2008
8Oxygen (Dioxygen)IBA
01/2021 - 10/2009
8Matrix Metalloproteinases (MMPs)IBA
10/2019 - 03/2007
8Apolipoproteins E (ApoE)IBA
11/2013 - 11/2002
8Receptor for Advanced Glycation End ProductsIBA
08/2010 - 05/2002
7Amyloid (Amyloid Fibrils)IBA
04/2022 - 02/2011
7Anesthetics (Anesthetic Agents)IBA
04/2022 - 10/2009
7CateninsIBA
01/2022 - 01/2019
7Interleukin-10 (Interleukin 10)IBA
01/2022 - 10/2011
7Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 08/2006
7SolutionsIBA
01/2022 - 01/2008
7Estrogen ReceptorsIBA
01/2022 - 02/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2010
7Retinaldehyde (Retinal)IBA
10/2021 - 08/2009

Therapy/Procedure

85Therapeutics
01/2022 - 01/2000
25Drug Therapy (Chemotherapy)
01/2022 - 12/2006
15Immunotherapy
03/2022 - 09/2003
14Lasers (Laser)
01/2022 - 07/2003
10Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2013
10Aftercare (After-Treatment)
05/2021 - 04/2006
9Electroacupuncture
06/2019 - 06/2009